Yu Wei
Zunyi, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Targeting astrocytic Nrf2 by Trilobatin alleviates lipopolysaccharide-induced depressive-like behaviors and cognitive impairment in mice: Mechanistic insights into gut microbiota and metabolites modulation.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 07, 2025
Targeting FDX1 by trilobatin to inhibit cuproptosis in doxorubicin-induced cardiotoxicity.
Journal: British journal of pharmacology
Published: November 10, 2024
Trilobatin, a Novel Naturally Occurring Food Additive, Ameliorates Alcoholic Liver Disease in Mice: Involvement of Microbiota-Gut-Liver Axis and Yap/Nrf2 Signaling Pathway.
Journal: Journal of agricultural and food chemistry
Published: August 22, 2024
Trilobatin suppresses aging-induced cognitive impairment by targeting SIRT2: Involvement of remodeling gut microbiota to mediate the brain-gut axis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 04, 2024
Lithocarpus polystachyus Rehd. leaves aqueous extract inhibits learning and memory impairment in Alzheimer's disease rats: Involvement of the SIRT6/NLRP3 signaling pathway.
Journal: Ibrain
Published: December 27, 2023
Trilobatin rescues fulminant hepatic failure by targeting COX2: Involvement of ROS/TLR4/NLRP3 signaling.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 28, 2023
Trilobatin, a Naturally Occurring Food Additive, Ameliorates Exhaustive Exercise-Induced Fatigue in Mice: Involvement of Nrf2/ARE/Ferroptosis Signaling Pathway.
Journal: Frontiers in pharmacology
Published: April 05, 2022
Trilobatin rescues cognitive impairment of Alzheimer's disease by targeting HMGB1 through mediating SIRT3/SOD2 signaling pathway.
Journal: Acta pharmacologica Sinica
Published: November 29, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026